Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts - A

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Organon & Co. (NYSE:OGN)

Dividend Yield: 9.13%
Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price target from $33 to $32 on Oct. 25, 2023. This analyst has an accuracy rate of 64%.
Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and slashed the price target from $27 to $22 on Oct. 11, 2023. This analyst has an accuracy rate of 69%.
Recent News: Organon posted weaker-than-expected results for the third quarter.

AbbVie Inc. (NYSE:ABBV)

Dividend Yield: 4.37%
Morgan Stanley analyst Terence Flynn maintained an Overweight rating and increased the price target from $193 to $196 on Oct. 30, 2023. This analyst has an accuracy rate of 69%.
Piper Sandler analyst Christopher Raymond maintained an Overweight rating and boosted the price target from $163 to $170 on July 28, 2023. This analyst has an accuracy rate of 64%.
Recent News: AbbVie reported better-than-expected earnings for its third quarter and raised its profit outlook.

Premier, Inc. (NASDAQ:PINC)

Dividend Yield: 4.24%
Baird analyst Eric Coldwell maintained a Neutral rating and cut the price target from $30 to $24 on Aug. 24, 2023. This analyst has an accuracy rate of 63%.
UBS analyst Kevin Caliendo maintained a Neutral rating and cut the price target from $29 to $26 on Aug. 23, 2023. This analyst has an accuracy rate of 77%.
Recent News: Premier posted stronger-than-expected earnings for its first quarter.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.